APA (7th ed.) Citation

M, F., M, R., V, B., P, W., A, B., A, K., . . . M, P. (2024). Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies. Nature communications, 15(1), 1583. https://doi.org/10.1038/s41467-024-45854-3

Chicago Style (17th ed.) Citation

M, Ferrari, et al. "Structure-guided Engineering of Immunotherapies Targeting TRBC1 and TRBC2 in T Cell Malignancies." Nature Communications 15, no. 1 (2024): 1583. https://doi.org/10.1038/s41467-024-45854-3.

MLA (9th ed.) Citation

M, Ferrari, et al. "Structure-guided Engineering of Immunotherapies Targeting TRBC1 and TRBC2 in T Cell Malignancies." Nature Communications, vol. 15, no. 1, 2024, p. 1583, https://doi.org/10.1038/s41467-024-45854-3.